arrow
B

Bryan J. Traynor

national institute on aging
H指数:92
被引数:4.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Association between Human Leukocyte Antigen Alleles and Neuropathological Outcomes in Lewy Body Disease

人类白细胞抗原等位基因与路易体病神经病理学结局的关联

2025-11-070
OAAI
Gene expression signatures from whole blood predict amyotrophic lateral sclerosis case status and survival

全血基因表达谱可预测肌萎缩侧索硬化症病例状态及生存情况

2025-10-310
OAAI
Integrating a motor domain enhances disease severity scales in an FTD-ALS spectrum cohort

整合一个马达结构域增强了FTD-ALS谱系队列中的疾病严重程度量表。

2025-10-280
OAAI
A plasma proteomics-based candidate biomarker panel predictive of amyotrophic lateral sclerosis

基于血浆蛋白质组学的肌萎缩侧索硬化症预测候选生物标志物组合

2025-08-190
OA
KIF5A p.Pro986Leu Risk Variant and Accelerated Progression of Amyotrophic Lateral Sclerosis

KIF5A p.Pro986Leu风险变异与肌萎缩侧索硬化的加速进展

2025-04-010
OAAI
CREB3 gain of function variants protect against ALS

CREB3 增强功能变体可预防 ALS

2025-03-260
OA
NeuroBooster Array: A Genome-Wide Genotyping Platform to Study Neurological Disorders Across Diverse Populations

Neurobster Array: 一个全基因组基因分型平台,用于研究不同人群的神经系统疾病

2024-09-164
OA
Intermediate HTT CAG repeats worsen disease severity in amyotrophic lateral sclerosis

中度HTT CAG重复使肌萎缩性侧索硬化症的疾病严重程度恶化

2024-09-060
PRE
Genome sequence analyses identify novel risk loci for multiple system atrophy

基因组序列分析确定多系统萎缩的新风险位点

NEURON
IF15
2024-07-013
OAAI
A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS-FTD

流体生物标志物揭示了症状前ALS中TDP-43剪接抑制的丧失-FTD

2024-01-2625
OAAI
Differential methylation analysis in neuropathologically confirmed dementia with Lewy bodies
2024-01-051
OAAI
Association of cardiovascular disease management drugs with Lewy body dementia: a case-control study

心血管疾病管理药物与路易体痴呆的关系: 一项病例对照研究

2023-12-183
OA